Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Spectral Medical Inc (EDTXF)

Spectral Medical Inc (EDTXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Spectral Medical Inc 135 The West Mall Unit 2 Toronto A6 M9C 1C2 CAN

https://spectraldx.com P: 416-626-3233

Description:

Spectral Medical Inc. develops and commercializes theranostic treatment for severe sepsis. The company's products include Endotoxin Activity Assay, a rapid diagnostic test for detection of components of gram negative bacterial cell wall; and Toraymyxin, a therapeutic hemoperfusion device for the treatment of sepsis that removes endotoxin from the bloodstream. Spectral Medical Inc., formerly known as Spectral Diagnostics Inc., is headquartered in Toronto, Canada.

Key Statistics

Overview:

Market Capitalization, $K 100,363
Enterprise Value, $K 98,173
Shares Outstanding, K 278,787
Annual Sales, $ 1,180 K
Annual Net Income, $ -11,600 K
Last Quarter Sales, $ 500 K
Last Quarter Net Income, $ -3,090 K
EBIT, $ -6,600 K
EBITDA, $ -5,840 K
60-Month Beta 0.82
% of Insider Shareholders 1.50%
% of Institutional Shareholders 0.00%
Float, K 274,605
% Float 98.50%
Short Volume Ratio 0.05

Growth:

1-Year Return 45.34%
3-Year Return -2.73%
5-Year Return 50.63%
5-Year Revenue Growth -60.14%
5-Year Earnings Growth -300.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.01 on 05/13/24
Next Earnings Date 05/10/24
Earnings Per Share ttm -0.05
EPS Growth vs. Prev Qtr 50.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

EDTXF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -263.26%
Profit Margin % -983.05%
Debt/Equity 0.00
Price/Sales 91.05
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.04
Interest Coverage -10.61
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar